title: Indenopyrazoles as novel cyclin dependent kinase (CDK) inhibitors.
authors: The DuPont Pharmaceuticals Company, Box 80336, Wilmington, Delaware 19880-0336, USA.
authors: D A
authors: DA
authors: Nugiel
authors: A M
authors: AM
authors: Etzkorn
authors: A
authors: A
authors: Vidwans
authors: P A
authors: PA
authors: Benfield
authors: M
authors: M
authors: Boisclair
authors: C R
authors: CR
authors: Burton
authors: S
authors: S
authors: Cox
authors: P M
authors: PM
authors: Czerniak
authors: D
authors: D
authors: Doleniak
authors: S P
authors: SP
authors: Seitz
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D018844:Cyclin-Dependent Kinases / Q000037:antagonists & inhibitors*; D004354:Drug Screening Assays, Antitumor; D004791:Enzyme Inhibitors / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D006801:Humans; D051379:Mice; D011720:Pyrazoles / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D013329:Structure-Activity Relationship; D014183:Transplantation, Heterologous; D014407:Tumor Cells, Cultured
chemical_list: D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D011720:Pyrazoles; D018844:Cyclin-Dependent Kinases